시장보고서
상품코드
1484746

세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 보고서(2024년)

Clinical Next-Generation Sequencing (NGS) Data Analysis Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 175 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

임상 차세대 시퀀싱(NGS) 데이터 분석 시장 규모는 향후 수년간 비약적인 성장이 전망됩니다. 2028년에는 CAGR 20.6%로 72억 5,000만 달러로 성장합니다. 예측 기간 중 예상되는 성장은 몇 가지 중요한 요인에 기인합니다. 첫째, 액체생검 기술의 채택이 증가하고 있습니다. 액체생검 기술은 유전 물질을 분석하고 질병의 진행을 모니터링하는 비침습적 방법을 제공합니다. 이러한 추세는 액체생검 샘플에서 종합적인 유전체 분석을 가능하게 하는 차세대 염기서열 분석(NGS) 기술에 대한 수요를 촉진할 것으로 예상됩니다. 또한 데이터 분석에 인공지능(AI)을 통합하면 게놈 해석의 효율성과 정확성이 향상될 것으로 예상되며, AI 알고리즘을 활용하면 NGS 데이터 분석이 질병과 관련된 유전자 변이를 보다 빠르고 정확하게 식별할 수 있도록 최적화되어 연구 및 임상 환경에서 NGS 용도의 성장을 가속할 것입니다. 용도의 성장을 더욱 촉진할 것입니다.

임상 차세대 시퀀싱 데이터 분석 시장은 맞춤형 의료에 대한 수요 증가에 힘입어 성장이 예상됩니다. 개인의 유전적, 환경적, 생활습관적 요인에 맞춘 맞춤의료는 유전체 기술, 질병의 복잡성, 치료성적의 향상, 의료비용의 상승으로 인해 주목받고 있습니다. 차세대 염기서열 분석(NGS) 데이터 분석은 맞춤형 의료에서 매우 중요한 역할을 하며, 여러 유전자의 신속하고 정확한 염기서열 분석을 용이하게 함으로써 개인의 유전자 프로파일을 더 잘 이해할 수 있게 합니다. 예를 들어 2022년 10월 데이터에 따르면 상당수의 유전자 검사 제품과 맞춤형 의약품이 보고되었고, 맞춤형 의약품이 신약 승인에서 주목할 만한 부분을 차지하고 있는 것으로 보아, NGS 데이터 분석이 맞춤형 의료의 채택을 촉진하는 데 필수적인 역할을 하고 있음을 알 수 있습니다.

임상 NGS 데이터 분석 시장의 주요 기업은 게놈 분석의 정확성에 대한 급증하는 요구 사항을 충족시키기 위해 기술 혁신을 추진하고 있으며, NextSeq 2000 시퀀싱 시스템과 같은 첨단 솔루션은 이 분야의 중요한 발전을 상징합니다. 이 시스템은 DNA 시퀀싱 프로세스를 간소화하도록 설계된 통합 하드웨어 및 소프트웨어 컴포넌트로 구성되어 DNA 분자 내의 정확한 뉴클레오티드 시퀀싱을 제공합니다. 예를 들어 Illumina Inc.가 2022년 9월에 발표한 NovaSeq X 시리즈는 생산 규모 시퀀싱의 패러다임을 바꾸고 속도, 성능 및 지속가능성을 향상시킨 제품으로, XLEAP-SBS 화학 및 초 고밀도 플로우 셀과 같은 혁신적인 기술을 활용하고 있습니다. 기술을 활용한 NovaSeq X 시리즈는 처리량과 시퀀싱 정확도를 크게 향상시켜 게놈 분석에 대한 수요 증가에 부응합니다.

목차

제1장 주요 요약

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • 시장에 대한 COVID-19의 영향

제5장 세계 시장 규모와 성장

  • 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 촉진요인과 억제요인
    • 시장 촉진요인
    • 시장 억제요인
  • 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장의 실적 : 규모와 성장, 2018-2023
  • 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 예측 : 규모와 성장, 2023-2028, 2033F

제6장 시장 세분화

  • 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 솔루션과 서비스별, 실적과 예측, 2018-2023, 2023-2028F, 2033F
  • NGS 데이터 분석 툴
  • NGS 데이터 분석 및 시퀀스 서비스
  • NGS 스토리지, 관리, 클라우드 컴퓨팅 플랫폼
  • 플랫폼
  • 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 기술별, 실적과 예측, 2018-2023, 2023-2028F, 2033F
  • SBS(Sequencing By Synthesis)
  • 나노포어 시퀀싱
  • 싱글 분자 실시간(SMRT) 시퀀싱
  • 기타 기술
  • 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 용도별, 실적과 예측, 2018-2023, 2023-2028F, 2033F
  • 진단
  • Drug Discovery와 설계
  • 의료 연구
  • 기타 용도
  • 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 최종사용자별, 실적과 예측, 2018-2023, 2023-2028F, 2033F
  • 병원과 진료소
  • 학술기관 및 연구 센터
  • 바이오테크놀러지 기업
  • 생명과학 기술 벤더
  • 기타 최종사용자

제7장 지역별·국가별 분석

  • 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 지역별, 실적과 예측, 2018-2023, 2023-2028F, 2033F
  • 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 국가별, 실적과 예측, 2018-2023, 2023-2028F, 2033F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

  • 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 경쟁 구도
  • 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 기업 개요
    • Roche Diagnostics
    • Thermo Fisher Scientific Inc.
    • Eurofins Scientific
    • Agilent Technologies Inc.
    • Illumina Inc.

제31장 기타 대기업과 혁신적 기업

  • PerkinElmer Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen
  • BGI Group
  • 10x Genomics
  • Genomic Health
  • Oxford Nanopore Technologies PLC.
  • Pacific Biosciences of California Inc.
  • Sophia Genetics
  • Genewiz
  • Partek Inc.
  • DNAnexus
  • BioNano Genomics
  • PierianDx
  • GENAPSYS

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 합병과 인수

제35장 전망과 잠재적 분석

제36장 부록

KSA 24.05.31

Clinical next-generation sequencing (NGS) data analysis is the interpretation of genetic information acquired through advanced sequencing technologies within a clinical context. These technologies enable the rapid and cost-effective sequencing of large DNA or RNA samples, allowing for the identification of genetic variations associated with diseases or conditions. This analytical process is essential for comprehending the genetic underpinnings of diseases, supporting personalized medicine approaches, and guiding clinical decision-making.

The main types of solutions and services in clinical next-generation sequencing (NGS) data analysis encompass NGS data analysis tools, NGS data analysis and sequencing services, and NGS storage, management, and cloud computing platforms. NGS data analysis tools are software applications designed to interpret and process the vast amount of data generated through NGS technologies. Leveraging various sequencing technologies such as sequencing by synthesis (SBS), nanopore sequencing, and single-molecule real-time (SMRT) sequencing, these tools find applications in diagnostics, drug discovery, medical research, and other domains. End-users of these tools span hospitals, clinics, academic institutes, research centers, biotechnology companies, and life science technology vendors.

The clinical next-generation sequencing (NGS) data analysis market research report is one of a series of new reports from The Business Research Company that provides clinical next-generation sequencing (NGS) data analysis market statistics, including clinical next-generation sequencing (NGS) data analysis industry global market size, regional shares, competitors with a clinical next-generation sequencing (NGS) data analysis market share, detailed clinical next-generation sequencing (NGS) data analysis market segments, market trends and opportunities, and any further data you may need to thrive in the clinical next-generation sequencing (NGS) data analysis industry. This clinical next-generation sequencing (NGS) data analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical next-generation sequencing data analysis market size has grown exponentially in recent years. It will grow from $2.86 billion in 2023 to $3.43 billion in 2024 at a compound annual growth rate (CAGR) of 20.1%. The growth observed in the historical period can be attributed to several key factors such as advancements have empowered researchers to delve deeper into the genetic basis of diseases and gain novel insights into human biology.

The clinical next-generation sequencing data analysis market size is expected to see exponential growth in the next few years. It will grow to $7.25 billion in 2028 at a compound annual growth rate (CAGR) of 20.6%. The anticipated growth in the forecast period can be attributed to several key factors. Firstly, there is a rising adoption of liquid biopsy techniques, which provide non-invasive methods for analyzing genetic material and monitoring disease progression. This trend is expected to drive the demand for next-generation sequencing (NGS) technologies, as they enable comprehensive genomic analysis from liquid biopsy samples. Additionally, the integration of artificial intelligence (AI) in data analysis is anticipated to enhance the efficiency and accuracy of genomic interpretation. By leveraging AI algorithms, NGS data analysis can be optimized for faster and more precise identification of genetic variations associated with diseases, further fueling the growth of NGS applications in both research and clinical settings.

The clinical next-generation sequencing data analysis market is poised for growth, propelled by the rising demand for personalized medicines. Personalized medicine, tailored to individual genetic, environmental, and lifestyle factors, gains prominence due to genomic technologies, increasing disease complexity, improved treatment outcomes, and escalating healthcare costs. Next-generation sequencing (NGS) data analysis plays a pivotal role in personalized medicine, facilitating rapid and accurate sequencing of multiple genes, thereby enhancing understanding of an individual's genetic profile. For example, data from October 2022 reports a significant number of genetic testing products and personalized medicines, with personalized medicines accounting for a notable portion of new drug approvals, underlining the integral role of NGS data analysis in driving personalized medicine adoption.

Key players in the clinical NGS data analysis market are innovating to meet burgeoning demands for genomic analysis accuracy. Advanced solutions such as the NextSeq 2000 Sequencing System represent significant developments in this realm. This system comprises integrated hardware and software components designed to streamline DNA sequencing processes, offering precise nucleotide sequencing within DNA molecules. For instance, Illumina Inc.'s September 2022 launch of the NovaSeq X Series introduces a paradigm shift in production-scale sequencing, boasting enhanced speed, power, and sustainability. Leveraging innovative technology such as XLEAP-SBS chemistry and ultra-high density flow cells, the NovaSeq X Series offers substantially increased throughput and sequencing accuracy, meeting the escalating demands for genomic analysis.

In March 2021, Integrated DNA Technologies (IDT) augmented its capabilities in the clinical NGS data analysis market through the acquisition of Swift Biosciences. This strategic move aims to enrich IDT's portfolio with Swift Biosciences' expertise in developing NGS library preparation kits, expanding genetic analysis capabilities across academic, translational, and clinical research domains. Swift Biosciences' NGS Library Preparation Kits cater to various research areas, including cancer, inherited diseases, agrigenomics, metagenomics, and pharmaceutical applications, complementing IDT's objective of delivering comprehensive genomic solutions.

Major companies operating in the clinical next-generation sequencing (NGS) data analysis market are Roche Diagnostics, Thermo Fisher Scientific Inc., Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen, BGI Group, 10x Genomics, Genomic Health, Oxford Nanopore Technologies PLC., Pacific Biosciences of California Inc., Sophia Genetics, Genewiz, Partek Inc., DNAnexus, BioNano Genomics, PierianDx, GENAPSYS, Nugen Technologies, DNAStar Inc., Swift Biosciences, Basepair, BioDatomics, Congenica Ltd., Theragen Etex Inc., Golden Helix Inc.

North America was the largest region in the clinical next-generation sequencing (NGS) data analysis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical next-generation sequencing (NGS) data analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the clinical next-generation sequencing (NGS) data analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical next-generation sequencing data analysis market consists of revenues earned by entities by providing services such as data preprocessing, alignment, variable calling, annotation, prioritization, interpretation, and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical next-generation sequencing data analysis market also includes sales of software tools, platforms, and pre-processing tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Next-Generation Sequencing (NGS) Data Analysis Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical next-generation sequencing (NGS) data analysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for clinical next-generation sequencing (NGS) data analysis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical next-generation sequencing (NGS) data analysis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Solution And Services: NGS Data Analysis Tools; NGS Data Analysis And Sequencing Services; NGS Storage, Management And Cloud Computing Platform; Platforms
  • 2) By Technology: Sequencing By Synthesis (SBS); Nanopore Sequencing; Single-Molecule Real-Time (SMRT) Sequencing; Other Technologies
  • 3) By Application: Diagnostics; Drug Discovery And Designing; Medical Research; Other Applications
  • 4) By End User: Hospitals And Clinics; Academic Institutes And Research Centers; Biotechnology Companies; Life Science Technology Vendors; Other End Users
  • Companies Mentioned: Roche Diagnostics; Thermo Fisher Scientific Inc.; Eurofins Scientific; Agilent Technologies Inc.; Illumina Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Characteristics

3. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Trends And Strategies

4. Clinical Next-Generation Sequencing (NGS) Data Analysis Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market Size and Growth

  • 5.1. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Segmentation

  • 6.1. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • NGS Data Analysis Tools
  • NGS Data Analysis And Sequencing Services
  • NGS Storage, Management And Cloud Computing Platform
  • Platforms
  • 6.2. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Sequencing By Synthesis (SBS)
  • Nanopore Sequencing
  • Single-Molecule Real-Time (SMRT) Sequencing
  • Other Technologies
  • 6.3. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diagnostics
  • Drug Discovery And Designing
  • Medical Research
  • Other Applications
  • 6.4. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Academic Institutes And Research Centers
  • Biotechnology Companies
  • Life Science Technology Vendors
  • Other End Users

7. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Regional And Country Analysis

  • 7.1. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 8.1. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 9.1. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 9.2. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 10.1. India Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 11.1. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 11.2. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 12.1. Australia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 13.1. Indonesia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 14.1. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 14.2. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 15.1. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 15.2. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 16.1. UK Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 17.1. Germany Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 18.1. France Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 19.1. Italy Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 20.1. Spain Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 21.1. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 21.2. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 22.1. Russia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 23.1. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 23.2. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 24.1. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 24.2. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 25.1. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 25.2. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 26.1. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 26.2. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 27.1. Brazil Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 28.1. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 28.2. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 29.1. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 29.2. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Competitive Landscape And Company Profiles

  • 30.1. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Competitive Landscape
  • 30.2. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Company Profiles
    • 30.2.1. Roche Diagnostics
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Eurofins Scientific
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Agilent Technologies Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Illumina Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Other Major And Innovative Companies

  • 31.1. PerkinElmer Inc.
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. Qiagen
  • 31.4. BGI Group
  • 31.5. 10x Genomics
  • 31.6. Genomic Health
  • 31.7. Oxford Nanopore Technologies PLC.
  • 31.8. Pacific Biosciences of California Inc.
  • 31.9. Sophia Genetics
  • 31.10. Genewiz
  • 31.11. Partek Inc.
  • 31.12. DNAnexus
  • 31.13. BioNano Genomics
  • 31.14. PierianDx
  • 31.15. GENAPSYS

32. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market Competitive Benchmarking

33. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Clinical Next-Generation Sequencing (NGS) Data Analysis Market

35. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Future Outlook and Potential Analysis

  • 35.1 Clinical Next-Generation Sequencing (NGS) Data Analysis Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Clinical Next-Generation Sequencing (NGS) Data Analysis Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Clinical Next-Generation Sequencing (NGS) Data Analysis Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제